INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$2.00 USD
-0.02 (-0.99%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.98 -0.02 (-1.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
INBS 2.00 -0.02(-0.99%)
Will INBS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for INBS
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y
Intelligent Bio Solutions Inc (INBS) Trading 13.29% Higher on Sep 9
Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission